Andlauer Healthcare Group Inc.

TSX:AND.TO

40.51 (CAD) • At close October 22, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q3
Revenue 161.446161.138169.067156.754157.357164.774165.772164.898169.402148.351133.025104.199107.12595.76686.63275.80570.25381.6574.79671.0471.14771.39672.09566.582
Cost of Revenue 125.03127.079128.194122.227122.076127.974123.78125.744127.1112.952100.6779.14479.15170.39665.04155.82452.39361.5358.93853.82654.49455.28259.2750.775
Gross Profit 36.41634.05940.87334.52735.28136.841.99239.15442.30235.39932.35525.05527.97425.3721.59119.98117.8620.1215.85817.21416.65316.11412.82515.807
Gross Profit Ratio 0.2260.2110.2420.220.2240.2230.2530.2370.250.2390.2430.240.2610.2650.2490.2640.2540.2460.2120.2420.2340.2260.1780.237
Reseach & Development Expenses 000000000000000000000000
General & Administrative Expenses 000000000000000000000000
Selling & Marketing Expenses 000000000000000000000000
SG&A 14.24112.81612.82912.80312.68613.1113.82611.29412.14511.23710.9038.2599.1828.7077.316.8166.7717.7164.2685.9495.2495.1924.195.767
Other Expenses 0.3040.009-0.5920.0390.1250.0190.063-0.2360.112-0.2670.264-0.0240.0120.116-0.0410.009-0.0190.002-0.190.024-0.007-0.0010.055-0.015
Operating Expenses 14.24112.81612.82912.80312.68613.1113.82611.29412.14511.23710.9038.2599.1828.7077.316.8166.7717.7164.2685.9495.2495.1924.195.767
Operating Income 22.17521.24328.04421.72422.59523.6928.16627.8630.15724.16221.45216.79618.79216.66314.28113.16511.08912.40411.4911.26511.40410.9228.63510.04
Operating Income Ratio 0.1370.1320.1660.1390.1440.1440.170.1690.1780.1630.1610.1610.1750.1740.1650.1740.1580.1520.1540.1590.160.1530.120.151
Total Other Income Expenses Net -0.702-0.875-2.2980.0390.125-1.315-1.408-1.896-1.574-1.70938.5560.980.8380.384-0.0410.009-0.0190.002-0.190.024-0.007-0.0010.055-0.015
Income Before Tax 21.47320.36825.74620.91821.56822.37526.75825.96428.58322.45358.47516.23117.9515.78413.24912.0889.89211.35110.52810.65410.84810.3178.1689.503
Income Before Tax Ratio 0.1330.1260.1520.1330.1370.1360.1610.1570.1690.1510.440.1560.1680.1650.1530.1590.1410.1390.1410.150.1520.1450.1130.143
Income Tax Expense 5.7425.4457.1855.5835.8525.8476.9346.9697.5985.9825.3714.0434.8994.173-0.623.4922.8253.1693.4392.8882.882.7782.2492.582
Net Income 15.73114.92318.56115.33515.71616.52819.82418.99520.98516.47153.10412.18813.05111.61113.8698.5967.0678.1827.0897.7637.6547.2815.726.653
Net Income Ratio 0.0970.0930.110.0980.10.10.120.1150.1240.1110.3990.1170.1220.1210.160.1130.1010.10.0950.1090.1080.1020.0790.1
EPS 0.380.360.450.370.370.390.470.450.50.391.270.320.340.310.370.230.190.220.190.220.210.20.160.18
EPS Diluted 0.380.350.440.360.370.390.460.440.490.391.250.310.330.30.360.220.180.220.190.220.210.20.160.18
EBITDA 39.77739.58345.36540.05540.29741.06845.0844.15846.33239.49873.72328.05130.00925.59222.00320.2517.99318.95118.14418.00318.03717.46615.12810.276
EBITDA Ratio 0.2460.2460.2680.2560.2560.2490.2720.2680.2740.2660.5540.2690.280.2670.2540.2670.2560.2320.2430.2530.2540.2450.210.154